CellRapeutics™ Leukopak from Colorectal Cancer Donor (XS-0426-XU276)

Name: CellRapeutics™ Leukopak from Colorectal Cancer Donor
SKU: XS-0426-XU276
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This Leukopak features a concentrated leucocyte population harvested from donors diagnosed with colorectal adenocarcinoma. The cellular profile captures the systemic immune response to gastrointestinal malignancy, often characterized by circulating tumor-reactive T cells and a distinct repertoire of myeloid-derived suppressor cells. This product is an essential resource for studying the "gut-immune-tumor" axis and validating biomarkers for colorectal cancer immunosurveillance and therapeutic resistance.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Colorectal Cancer Donor

Cat. No.
XS-0426-XU276

Donor Age
Senior

Donor Health
Diagnosed with colorectal malignancy. The leukocyte profile reflects the host's systemic response to intestinal oncogenesis, including alterations in tumor-associated monocytic subsets and anti-tumor T-cell memory.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Acid Citrate Dextrose, optimized to protect the gut-homing markers and the cytotoxic efficacy of tumor-reactive T cells.

Additional Donor Information
Each lot features a Leukopak from donors with histologically confirmed colorectal carcinoma. Profiles include TNM staging, anatomical location, and treatment history to support research into peripheral immune signatures of gastrointestinal malignancies.

Clinical Profile
Primary tumor location, TNM staging, MSI/MSS status, and history of surgical resection, chemotherapy, or radiotherapy.

Additional Information

Medication History
Available upon request. Records of fluoropyrimidine-based chemotherapy, anti-VEGF/EGFR biologics, and immune checkpoint inhibitors.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Colorectal Cancer Donor, Leukopak, Colorectal Cancer

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Colorectal Cancer Donor (XS-0426-XU276). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.